This precision medicine company just raised $ 5 million to help save premature babies
Astarte Medical, a Yardley, Pa., precision medicine-based software company, announced on Tuesday that it had raised a $ 5 million Series A round led by Keiretsu MidAtlantic Forum.
The company, founded in 2016 by former investors Tracy warren and Tammi Jantzen, will use the funding to complete the development of its flagship product: NICUTrition, a suite of digital tools and diagnostics that supports feeding protocols, practice, and decision-making in neonatal intensive care units (NICUs).
Ben Franklin Technology Partners, Viking Global Investors LP, Lunsford Capital, OCA Ventures, Keiretsu Capital Fund, Wing VC and Next Act Fund also joined the tour.
“This funding will bring us closer to finalizing our suite of solutions to address the unmet needs of the NICU to improve outcomes for premature infants, such as improved growth and minimized risk of infection,” said Warren, who is also the CEO of the company.
According to Warren, the current NICU feeding protocols are complex and must be followed manually, which confuses staff. Astarte’s product seeks to automate feeding protocols and use quantitative data on the gut health of premature babies to provide personalized care and nutrition.
(Based in city center Keriton Also targets neonatal intensive care units, although its solution focuses on managing breast milk and formula.)
Find out more about the Astarte platform: